{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:48:16Z","timestamp":1780109296195,"version":"3.54.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"A.P. M\u00f8ller og Hustru Chastine Mc-Kinney M\u00f8llers Fond til almene Formaal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In histologically atypical congenital hyperinsulinism (CHI), correlations between clinical, histological and genetic features are largely unknown. Laser-capture microdissection may be used to identify low-grade mosaic DNA variants in the islets of Langerhans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate genotype-histotype-phenotype correlations histologically in atypical CHI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In our single-center cohort of hyperinsulinemic hypoglycemia (HH) patients, 77 underwent pancreatic surgery. In those with histologically atypical CHI, genetic analyses included sequencing of frequent CHI genes from blood and bulk pancreatic tissue and tests for Beckwith-Wiedemann Syndrome (BWS) where appropriate. If negative, a targeted 140-gene panel including the non-coding region of\n                      <jats:italic>HK1<\/jats:italic>\n                      was performed in blood, pancreatic bulk tissue and islets isolated by laser-capture microdissection. Histological, immunohistochemical and morphometric analyses were performed on pancreatic tissue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 77 HH patients were classified histologically as K\n                      <jats:sub>ATP<\/jats:sub>\n                      -channel focal CHI (n=48), K\n                      <jats:sub>ATP<\/jats:sub>\n                      -channel diffuse CHI (n=14), insulinoma (n=6), non-insulinoma HH in teenagers (n=1), BWS (n=1), unclassified (n=2). Histologically atypical CHI patients (n=5\/70; 7.1%) had a median (range) birth weight of 2965 (2650-3385) grams and a clinical disease onset at 93 (1-259) days. 18F-DOPA PET\/CT showed diffuse tracer uptake. In three patients, genetic analysis showed\n                      <jats:italic>HK1<\/jats:italic>\n                      intron 2 variants, of which one was present in germline (\n                      <jats:italic>de novo<\/jats:italic>\n                      heterozygous) while the other two had somatic low-grade mosaic alterations in bulk pancreatic tissue (n=1) or exclusively in islets after isolation by laser-capture microdissection (n=1). Patient 4 showed a\n                      <jats:italic>CACNA1D<\/jats:italic>\n                      frameshift mutation suggesting Cav1.3-channel gain-of-function properties. No relevant genetic changes were found in Patient 5. In all five atypical CHI specimens, pancreatic histology showed slight changes with areas having pronounced occurrence of large islets of Langerhans, while small islets and endocrine cell clusters were evenly distributed. Giant cell nuclei were observed, but at much lower frequencies compared to K\n                      <jats:sub>ATP<\/jats:sub>\n                      -channel diffuse CHI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Histologically atypical CHI was seen in 7.1% of surgically treated CHI patients and characterized by discrete changes with enlarged islets of Langerhans and a low frequency of giant nuclei in endocrine cells. Genetics showed heterozygous or low-grade mosaic\n                      <jats:italic>HK1<\/jats:italic>\n                      intron 2 DNA variants in three patients. Low-grade mosaic pancreatic genetic changes may only be detectable after islet isolation by laser-capture microdissection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1692539","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:31:48Z","timestamp":1767591108000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Germline and somatic mutations in histologically atypical congenital hyperinsulinism"],"prefix":"10.3389","volume":"16","author":[{"given":"Annette R\u00f8nholt","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Globa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte Caroline","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Limbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa L\u00f6fgren","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lerberg","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Bau","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Kildall","family":"Hejb\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brusgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6nke","family":"Detlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Thybo","family":"Christesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0228417","DOI":"10.1371\/journal.pone.0228417","article-title":"Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389","volume":"15","author":"Yau","year":"2020","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.873254","article-title":"Congenital hyperinsulinism: current laboratory-based approaches to the genetic diagnosis of a heterogeneous disease","volume":"13","author":"Hewat","year":"2022","journal-title":"Front Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0673","article-title":"Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism","volume":"168","author":"Kapoor","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-02961-6_2","article-title":"Diazoxide-responsive forms of congenital hyperinsulinism","volume-title":"Congenital hyperinsulinism A practical guide to diagnosis and management","author":"Yau","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000531766","article-title":"International guidelines for the diagnosis and management of hyperinsulinism","volume":"97","author":"De Leon","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1013874","article-title":"Syndromic forms of congenital hyperinsulinism","volume":"14","author":"Zenker","year":"2023","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904153401505","article-title":"Clinical features of 52 neonates with hyperinsulinism","volume":"340","author":"de Lonlay-Debeney","year":"1999","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0673","article-title":"Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism","volume":"93","author":"Damaj","year":"2008","journal-title":"JClin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-709","article-title":"Genotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia","volume":"39","author":"Larsen","year":"2024","journal-title":"Histol Histopathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.9.2433","article-title":"Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations","volume":"52","author":"Gloyn","year":"2003","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.2164","article-title":"Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation","volume":"53","author":"Cuesta-Mu\u00f1oz","year":"2004","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02285.x","article-title":"Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy","volume":"24","author":"Wabitsch","year":"2007","journal-title":"Diabetes Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0909845","article-title":"Large islets, beta-cell proliferation, and a glucokinase mutation","volume":"362","author":"Kassem","year":"2010","journal-title":"New Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2003.10.013","article-title":"Hyperinsulinism\/hyperammonemia syndrome: insights into the regulatory role of glutamate dehydrogenase in ammonia metabolism","author":"Stanley","year":"2004","journal-title":"Mol Genet Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200109000-00010","article-title":"Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients","volume":"50","author":"De Lonlay","year":"2001","journal-title":"Pediatr Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.sempedsurg.2010.10.010","article-title":"Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism","volume":"20","author":"Rahier","year":"2011","journal-title":"Semin Pediatr Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/cen.14393","article-title":"Syndromic forms of hyperinsulinaemic hypoglycaemia-A 15-year follow-up study","volume":"94","author":"Kostopoulou","year":"2021","journal-title":"Clin Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-3032","article-title":"Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy","volume":"96","author":"Sempoux","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1414","article-title":"Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of \u03b2-cells","volume":"62","author":"Henquin","year":"2013","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1095","article-title":"Localized islet nuclear enlargement hyperinsulinism (LINE-HI) due to ABCC8 and GCK mosaic mutations","volume":"187","author":"Boodhansingh","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000526203","article-title":"Mosaic GLUD1 mutations associated with hyperinsulinism hyperammonemia syndrome","volume":"95","author":"Boodhansingh","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae713","article-title":"Low-level mosaic GCK mutations in children with diazoxide-unresponsive congenital hyperinsulinism","volume":"110","author":"Boodhansingh","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01204-x","article-title":"Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism","volume":"54","author":"Wakeling","year":"2022","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.614993","article-title":"A sensitive plasma insulin immunoassay to establish the diagnosis of congenital hyperinsulinism","volume":"11","author":"Siersb\u00e6k","year":"2020","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12989","article-title":"The difficult management of persistent, non-focal congenital hyperinsulinism: A retrospective review from a single, tertiary center","volume":"21","author":"Rasmussen","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3867-1","article-title":"18F-DOPA PET\/CT and 68Ga-DOTANOC PET\/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation","volume":"45","author":"Christiansen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1497579","article-title":"Congenital hyperinsulinism in the Ukraine: a 10-year national study","volume":"15","author":"Globa","year":"2024","journal-title":"Front Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"103632","DOI":"10.1016\/j.ejmg.2019.02.004","article-title":"Tissue variations of mosaic genome-wide paternal uniparental disomy and phenotype of multi-syndromal congenital hyperinsulinism","volume":"63","author":"Christesen","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015244","article-title":"Integration of genomic analysis and transcript expression of ABCC8 and KCNJ11 in focal form of congenital hyperinsulinism","volume":"13","author":"Wieland","year":"2022","journal-title":"Front Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00478","article-title":"Intraoperative ultrasound: A tool to support tissue-sparing curative pancreatic resection in focal congenital hyperinsulinism","volume":"9","author":"Bendix","year":"2018","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-025-01440-w","article-title":"Non\u2212coding cis\u2212regulatory variants in HK1 cause congenital hyperinsulinism with variable disease severity","volume":"17","author":"Bennett","year":"2025","journal-title":"Gen Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31953-1","article-title":"Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels","volume":"269","author":"Becker","year":"1994","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12512","article-title":"A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia","volume":"18","author":"Flanagan","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/19336950.2020.1761171","article-title":"de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia","volume":"14","author":"De Mingo Alemany","year":"2020","journal-title":"Channels"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158097","article-title":"Hyperinsulinemic hypoglycemia associated with a ca(V)1.2 variant with mixed gain- and loss-of-function effects","volume":"23","author":"Kummer","year":"2022","journal-title":"Int JMolSci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13023-021-01850-0","article-title":"Calcium channelopathies and intellectual disability: a systematic review","volume":"16","author":"Kessi","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003085","article-title":"Dominant role of CACNA1D exon mutations for blood pressure regulation","volume":"40","author":"Wang","year":"2022","journal-title":"J Hypertens"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21229","article-title":"CACNA1D gene polymorphisms associate with increased blood pressure and salt sensitivity of blood pressure in white individuals","volume":"80","author":"Stanton","year":"2023","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/db23-0465","article-title":"Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations","volume":"72","author":"Li","year":"2023","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae459","article-title":"Clinical and genetic characteristics of congenital hyperinsulinism in Norway: A nationwide cohort study","volume":"110","author":"Velde","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1373\/clinchem.2014.223040","article-title":"Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization","volume":"61","author":"Do","year":"2015","journal-title":"Clin Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1692539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:31:49Z","timestamp":1767591109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1692539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":43,"alternative-id":["10.3389\/fendo.2025.1692539"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1692539","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1692539"}}